Expression of Inflammation-Associated MicroRNAs in Epilepsy

Bibliographic Details
Main Author: Leal, Bárbara
Publication Date: 2015
Other Authors: Carvalho, Cláudia, Chaves, João, Bettencourt, Andreia, Freitas, Joel, Lopes, João, Ramalheira, João, Silva, António M., Costa, Paulo P., Silva, Berta M.
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.18/3578
Summary: Background: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies.
id RCAP_c54b76e85af01bc5b8155e3ee0fe1798
oai_identifier_str oai:repositorio.insa.pt:10400.18/3578
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Expression of Inflammation-Associated MicroRNAs in EpilepsyImmunobiologyMesial Temporal Lobe Epilepsy with Hippocampal SclerosismiRNAsEpigeneticsInflammationDeterminantes da Saúde e da DoençaDoenças GenéticasBackground: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies.Repositório Científico do Instituto Nacional de SaúdeLeal, BárbaraCarvalho, CláudiaChaves, JoãoBettencourt, AndreiaFreitas, JoelLopes, JoãoRamalheira, JoãoSilva, António M.Costa, Paulo P.Silva, Berta M.2016-03-02T15:46:23Z2015-10-282015-10-28T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.18/3578enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-26T14:24:18Zoai:repositorio.insa.pt:10400.18/3578Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T21:39:10.101471Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Expression of Inflammation-Associated MicroRNAs in Epilepsy
title Expression of Inflammation-Associated MicroRNAs in Epilepsy
spellingShingle Expression of Inflammation-Associated MicroRNAs in Epilepsy
Leal, Bárbara
Immunobiology
Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
miRNAs
Epigenetics
Inflammation
Determinantes da Saúde e da Doença
Doenças Genéticas
title_short Expression of Inflammation-Associated MicroRNAs in Epilepsy
title_full Expression of Inflammation-Associated MicroRNAs in Epilepsy
title_fullStr Expression of Inflammation-Associated MicroRNAs in Epilepsy
title_full_unstemmed Expression of Inflammation-Associated MicroRNAs in Epilepsy
title_sort Expression of Inflammation-Associated MicroRNAs in Epilepsy
author Leal, Bárbara
author_facet Leal, Bárbara
Carvalho, Cláudia
Chaves, João
Bettencourt, Andreia
Freitas, Joel
Lopes, João
Ramalheira, João
Silva, António M.
Costa, Paulo P.
Silva, Berta M.
author_role author
author2 Carvalho, Cláudia
Chaves, João
Bettencourt, Andreia
Freitas, Joel
Lopes, João
Ramalheira, João
Silva, António M.
Costa, Paulo P.
Silva, Berta M.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Leal, Bárbara
Carvalho, Cláudia
Chaves, João
Bettencourt, Andreia
Freitas, Joel
Lopes, João
Ramalheira, João
Silva, António M.
Costa, Paulo P.
Silva, Berta M.
dc.subject.por.fl_str_mv Immunobiology
Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
miRNAs
Epigenetics
Inflammation
Determinantes da Saúde e da Doença
Doenças Genéticas
topic Immunobiology
Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
miRNAs
Epigenetics
Inflammation
Determinantes da Saúde e da Doença
Doenças Genéticas
description Background: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies.
publishDate 2015
dc.date.none.fl_str_mv 2015-10-28
2015-10-28T00:00:00Z
2016-03-02T15:46:23Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/3578
url http://hdl.handle.net/10400.18/3578
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599365090902016